Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery

Narutoshi Hibino, A. Kawai, S. Uchikawa, G. Chikazawa, T. Kurihara, S. Kihara, K. Uebe, S. Aomi, H. Nishida, M. Endo, H. Koyanagi

Research output: Contribution to journalArticle

Abstract

Colforsin daropate hydrochloride (COL) is a novel drug for the treatment of acute heart failure. COL stimulates adenylate cyclase directly and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP. We investigated its cardiovascular effects for 9 patients who showed low cardiac index (< 3.0 l/min/m2) after open-heart surgery in ICU. After 2 or 3 hours from administration of COL, heart rate and cardiac index increased, and pulmonary artery pressure and central venous pressure decreased significantly, but blood pressure and systemic venous oxygen saturation did not show significant change. In conclusion, COL improved hemodynamics through positive inotropic and vasodilator effects without hypotension. We should investigate more proper usage of this drug to avoid such side effects as tachycardia and arrhythmia, which occurred in some cases.

Original languageEnglish (US)
Pages (from-to)1016-1019
Number of pages4
JournalKyobu geka. The Japanese journal of thoracic surgery
Volume54
Issue number12
StatePublished - 2001
Externally publishedYes

Fingerprint

Vasodilator Agents
Thoracic Surgery
Heart Failure
Central Venous Pressure
Venous Pressure
Adenylyl Cyclases
Tachycardia
Pharmaceutical Preparations
Hypotension
Pulmonary Artery
Cardiac Arrhythmias
Heart Rate
Hemodynamics
Oxygen
Pressure
colforsin daropate
Therapeutics

Cite this

Hibino, N., Kawai, A., Uchikawa, S., Chikazawa, G., Kurihara, T., Kihara, S., ... Koyanagi, H. (2001). Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery. Kyobu geka. The Japanese journal of thoracic surgery, 54(12), 1016-1019.

Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery. / Hibino, Narutoshi; Kawai, A.; Uchikawa, S.; Chikazawa, G.; Kurihara, T.; Kihara, S.; Uebe, K.; Aomi, S.; Nishida, H.; Endo, M.; Koyanagi, H.

In: Kyobu geka. The Japanese journal of thoracic surgery, Vol. 54, No. 12, 2001, p. 1016-1019.

Research output: Contribution to journalArticle

Hibino, N, Kawai, A, Uchikawa, S, Chikazawa, G, Kurihara, T, Kihara, S, Uebe, K, Aomi, S, Nishida, H, Endo, M & Koyanagi, H 2001, 'Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery', Kyobu geka. The Japanese journal of thoracic surgery, vol. 54, no. 12, pp. 1016-1019.
Hibino, Narutoshi ; Kawai, A. ; Uchikawa, S. ; Chikazawa, G. ; Kurihara, T. ; Kihara, S. ; Uebe, K. ; Aomi, S. ; Nishida, H. ; Endo, M. ; Koyanagi, H. / Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery. In: Kyobu geka. The Japanese journal of thoracic surgery. 2001 ; Vol. 54, No. 12. pp. 1016-1019.
@article{f7947baf0c2e4532835461e895217cb8,
title = "Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery",
abstract = "Colforsin daropate hydrochloride (COL) is a novel drug for the treatment of acute heart failure. COL stimulates adenylate cyclase directly and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP. We investigated its cardiovascular effects for 9 patients who showed low cardiac index (< 3.0 l/min/m2) after open-heart surgery in ICU. After 2 or 3 hours from administration of COL, heart rate and cardiac index increased, and pulmonary artery pressure and central venous pressure decreased significantly, but blood pressure and systemic venous oxygen saturation did not show significant change. In conclusion, COL improved hemodynamics through positive inotropic and vasodilator effects without hypotension. We should investigate more proper usage of this drug to avoid such side effects as tachycardia and arrhythmia, which occurred in some cases.",
author = "Narutoshi Hibino and A. Kawai and S. Uchikawa and G. Chikazawa and T. Kurihara and S. Kihara and K. Uebe and S. Aomi and H. Nishida and M. Endo and H. Koyanagi",
year = "2001",
language = "English (US)",
volume = "54",
pages = "1016--1019",
journal = "Japanese Journal of Thoracic Surgery",
issn = "0021-5252",
publisher = "Nankodo Co., Ltd.",
number = "12",

}

TY - JOUR

T1 - Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery

AU - Hibino, Narutoshi

AU - Kawai, A.

AU - Uchikawa, S.

AU - Chikazawa, G.

AU - Kurihara, T.

AU - Kihara, S.

AU - Uebe, K.

AU - Aomi, S.

AU - Nishida, H.

AU - Endo, M.

AU - Koyanagi, H.

PY - 2001

Y1 - 2001

N2 - Colforsin daropate hydrochloride (COL) is a novel drug for the treatment of acute heart failure. COL stimulates adenylate cyclase directly and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP. We investigated its cardiovascular effects for 9 patients who showed low cardiac index (< 3.0 l/min/m2) after open-heart surgery in ICU. After 2 or 3 hours from administration of COL, heart rate and cardiac index increased, and pulmonary artery pressure and central venous pressure decreased significantly, but blood pressure and systemic venous oxygen saturation did not show significant change. In conclusion, COL improved hemodynamics through positive inotropic and vasodilator effects without hypotension. We should investigate more proper usage of this drug to avoid such side effects as tachycardia and arrhythmia, which occurred in some cases.

AB - Colforsin daropate hydrochloride (COL) is a novel drug for the treatment of acute heart failure. COL stimulates adenylate cyclase directly and produces positive inotropic and vasodilator effects accompanied by the increase in cellular cAMP. We investigated its cardiovascular effects for 9 patients who showed low cardiac index (< 3.0 l/min/m2) after open-heart surgery in ICU. After 2 or 3 hours from administration of COL, heart rate and cardiac index increased, and pulmonary artery pressure and central venous pressure decreased significantly, but blood pressure and systemic venous oxygen saturation did not show significant change. In conclusion, COL improved hemodynamics through positive inotropic and vasodilator effects without hypotension. We should investigate more proper usage of this drug to avoid such side effects as tachycardia and arrhythmia, which occurred in some cases.

UR - http://www.scopus.com/inward/record.url?scp=0035512326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035512326&partnerID=8YFLogxK

M3 - Article

C2 - 11712370

AN - SCOPUS:0035512326

VL - 54

SP - 1016

EP - 1019

JO - Japanese Journal of Thoracic Surgery

JF - Japanese Journal of Thoracic Surgery

SN - 0021-5252

IS - 12

ER -